![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | H01L 29/02 | (2006.01) |
A61K 31/445 | (2013.01) | ||
C07D 211/44 | (2013.01) | ||
H01L 28/90 | (2013.01) | ||
A61P 25/00 | (2018.01) |
(11) | Number of the document | 2831043 |
(13) | Kind of document | T |
(96) | European patent application number | 13710951.8 |
Date of filing the European patent application | 2013-03-07 | |
(97) | Date of publication of the European application | 2015-02-04 |
(45) | Date of publication and mention of the grant of the patent | 2022-07-27 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2013/029612 |
Date | 2013-03-07 |
(87) | Number | WO 2013/148103 |
Date | 2013-10-03 |
(30) | Number | Date | Country code |
201261616159 P | 2012-03-27 | US |
(72) |
BOYD, Robert , US
RYBCZYNSKI, Philip, J. , US
SHETH, Kamlesh , US
|
(73) |
Amicus Therapeutics, Inc. ,
3675 Market Street, Philadelphia, PA 19104,
US
|
(54) | NOVEL COMPOUNDS FOR PREVENTING AND/OR TREATING LYSOSOMAL STORAGE DISORDERS AND/OR DEGENERATIVE DISORDERS OF THE CENTRAL NERVOUS SYSTEM |
NOVEL COMPOUNDS FOR PREVENTING AND/OR TREATING LYSOSOMAL STORAGE DISORDERS AND/OR DEGENERATIVE DISORDERS OF THE CENTRAL NERVOUS SYSTEM |